Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0800
0.00 (0.00%)
At close: Aug 1, 2025, 4:00 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 5.77 million as of August 1, 2025. Its market cap has decreased by -57.49% in one year.
Market Cap
5.77M
Enterprise Value
14.41M
Revenue
295.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 5.77M, an increase of 85.23%. That is a compound annual growth rate of 4.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.77M | -37.41% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | 44.70M | 1.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.40B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.69B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |